| Title： | Management of Idiopathic Steroid-Senisitive Nephrotic Syndrome (SSNS) in Children |
| Edition： | Adapted |
| Classification： | Standard guideline |
| Field： | Diagnosis and Treatment |
| Countries and regions： | Saudi Arabia |
| Guidelines users： | Pediatric nephrologists, general pediatricians, pharmacists, and nurses with relevant nephrology experience in children in the Saudi Arabian secondary and tertiary healthcare settings. |
| Evidence classification method： | This will be decided later based on the classification system used by the Source CPG(s) that will be selected for adaptation to the Saudi Arabian healthcare context. GRADE method would be a preference during the selection (if applicable). A formal methodology for CPG adaptation will be used, the 'King Saud University (KSU) Modified ADAPTE', in which the Appraisal of Guidelines for Research & Evaluation (AGREE) II Instrument is a main step during the quality assessment of the eligible Source CPGs. |
| Development unit： | Saudi Society for Nephrology and Transplantation (SSN & T) |
| Registration time: | 2021-03-19 |
| Registration number： | IPGRP-2021CN060 |
| Purpose of the guideline: | To unify the practice between centers and improve patient outcomes and experience for children with Idiopathic Steroid-Senisitive Nephrotic Syndrome (SSNS). Specific objectives include prevention of disease relapse, inform the appropriateness of prescription [duration of steroid courses in newly diagnosed children with SNSS, drug of choice for the second relapse in Steroid-Dependent Nephrotic Syndrome (SDNS) and Frequent-relapsing Nephrotic Syndrome (FRNS) in children]. |
Latest registration
